IceCure Medical Ltd
ICCM
$2.54
-$0.27-9.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 6.24% | 19.89% | -7.95% | ||
| Total Depreciation and Amortization | -30.34% | 8.54% | -1.20% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -48.81% | -25.33% | 11.39% | ||
| Change in Net Operating Assets | 157.28% | -2,973.91% | -103.23% | ||
| Cash from Operations | 30.39% | 3.74% | -33.05% | ||
| Capital Expenditure | -266.67% | -20.00% | 84.38% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -100.24% | ||
| Cash from Investing | -283.33% | 14.29% | -100.87% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -96.68% | 61.34% | -52.72% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -18.62% | 132.70% | -67.22% | ||
| Foreign Exchange rate Adjustments | 319.05% | -600.00% | -175.00% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 56.89% | 50.95% | -404.91% | ||